Tag Archives: cancer

Germany Allows Chronic Pain Sufferers to Grow Their Own Cannabis

This seems like a phenomenal idea. This allows the patient to put their care into their own hands. I wish America would follow suit on this. Cultivating your own medicine and regulating your dosage allows for a sense of control usually lost on patients who use medical marijuana for legitimate purposes.

Article courtesy of Fox News. Please click here for original article.

Published July 22, 2014

(REUTERS/Andres Stapff)

A German court ruled on Tuesday that some people suffering from chronic pain should be able to cultivate their own cannabis “for therapeutic purposes”.

Five people suffering from chronic pain brought the complaint to a court in Cologne after Germany’s Federal Institute for Drugs and Medical Devices (BfArM) refused them permission to grow the plant at home.

The court said the BfArM had to reconsider three of the requests that it had rejected.

While the plaintiffs all had permits to buy and consume cannabis for therapeutic purposes, they wanted to cultivate their own because they could not afford to purchase the drug and their health insurance did not cover it.

Read the rest of this entry »


Tags: , , , , , , , , , , , , , , , ,

Men, Opiods, and Low Testosterone Levels

As a man, with chronic pain, and taking long-acting pain meds, I found this article interesting and yet disturbing at the same time. What are we to do? We take pain meds to get through the day and then have to add a testosterone supplement later in life? I by no means think that life is fair, but can’t we catch a break? Just an itsy-bitsy one?

Men Taking Long-Acting Chronic Pain Meds Five Times More Likely to Have Low Testosterone Levels

Jan. 31, 2013 — Low testosterone levels occur five times more often among men who take long-acting instead of short-acting opioids for chronic pain, according to a new Kaiser Permanente study published in The Clinical Journal of Pain.

While it has been known that opioids cause low testosterone in men, this study is the first to show a significant difference in risk between short-acting (immediate release) and long-acting opioids.

The 81 men in the retrospective study were between 26 and 79 years old (median age 51) and were seen in the chronic-pain clinic at Kaiser Permanente’s Santa Rosa Medical Center (Calif.) between January 2009 and June 2010. All of the participants had been on a stable dose of an opioid for at least three months, and none had a previous diagnosis of low testosterone. A larger retrospective study of more than 1,500 male pain patients is currently under way.

“There’s a large gap in the evidence base with regard to opioids,” said Andrea Rubinstein, MD, of the Departments of Chronic Pain and Anesthesiology, Kaiser Permanente Santa Rosa Medical Center. “More safety and efficacy studies are needed. We need to know how we can prescribe these very useful medications in a way that brings the greatest benefits to our patients, without introducing additional risks.”

Once prescribed primarily to cancer patients, the use of opioid-based medications such as oxycodone (Oxycontin) and hydrocodone (Vicodin) for treating chronic, non-cancer pain has increased dramatically in recent decades. An estimated 4.3 million Americans use opioids on a daily basis for pain.

Read the rest of this entry »


Tags: , , , , , , , ,

More “Experts” Frown on Using Opiods to Treat Chronic Pain

Yet another reason why those without chronic pain should stay out of our business. I truly understand that we have a problem in America with abuse of prescription pain medication which is why I am all for more follow ups with your PCP. However, if the only thing that works for your pain is Opiods, the government and the experts need to back off a little. Soon, it will become impossible for those in need such as ourselves to get the care we need because of the opinions of those on the outside looking in.

Opioids for chronic noncancer pain discouraged
Published on July 12, 2012 at 5:15 PM
By Caroline Price

US experts have called for more selective and cautious opioid prescribing for chronic noncancer pain, because of concerns over misuse of the drugs and continued uncertainty over when and for how long they should be prescribed.

In a collection of related articles in the current Annals of Family Medicine, they highlight concerns surrounding opioid use and misuse among primary care patients, and the lack of clear guidance on safe use of the drugs in this setting.

Family physicians Roger Rosenblatt and Mary Catlin, from the University of Washington in Seattle, write: “Entering into chronic opioid therapy requires a long-term commitment by clinicians and patient alike to use this powerful, precious, and dangerous medication with care and diligence.”

Read the rest of this entry »


Tags: , ,